BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37666816)

  • 1. Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines.
    Shoer S; Shilo S; Godneva A; Ben-Yacov O; Rein M; Wolf BC; Lotan-Pompan M; Bar N; Weiss EI; Houri-Haddad Y; Pilpel Y; Weinberger A; Segal E
    Nat Commun; 2023 Sep; 14(1):5384. PubMed ID: 37666816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes.
    Ben-Yacov O; Godneva A; Rein M; Shilo S; Lotan-Pompan M; Weinberger A; Segal E
    Gut; 2023 Aug; 72(8):1486-1496. PubMed ID: 37137684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: a randomized controlled trial.
    Rinott E; Meir AY; Tsaban G; Zelicha H; Kaplan A; Knights D; Tuohy K; Scholz MU; Koren O; Stampfer MJ; Wang DD; Shai I; Youngster I
    Genome Med; 2022 Mar; 14(1):29. PubMed ID: 35264213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mediterranean Diet on plasma metabolites and their relationship with insulin resistance and gut microbiota composition in a crossover randomized clinical trial.
    Galié S; García-Gavilán J; Papandreou C; Camacho-Barcía L; Arcelin P; Palau-Galindo A; Rabassa A; Bulló M
    Clin Nutr; 2021 Jun; 40(6):3798-3806. PubMed ID: 34130026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota predicts body fat change following a low-energy diet: a PREVIEW intervention study.
    Jian C; Silvestre MP; Middleton D; Korpela K; Jalo E; Broderick D; de Vos WM; Fogelholm M; Taylor MW; Raben A; Poppitt S; Salonen A
    Genome Med; 2022 May; 14(1):54. PubMed ID: 35599315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiome Composition and Serum Metabolome Profile Among Individuals With Spinal Cord Injury and Normal Glucose Tolerance or Prediabetes/Type 2 Diabetes.
    Li J; Morrow C; Barnes S; Wilson L; Womack ED; McLain A; Yarar-Fisher C
    Arch Phys Med Rehabil; 2022 Apr; 103(4):702-710. PubMed ID: 34126067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population.
    Bourdeau-Julien I; Castonguay-Paradis S; Rochefort G; Perron J; Lamarche B; Flamand N; Di Marzo V; Veilleux A; Raymond F
    Microbiome; 2023 Feb; 11(1):26. PubMed ID: 36774515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a high dietary intake of resistant starch affect glycaemic control and alter the gut microbiome in women with gestational diabetes? A randomised control trial protocol.
    Latino C; Gianatti EJ; Mehta S; Lo J; Devine A; Christophersen C
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):46. PubMed ID: 35042457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact drugs targeting cardiometabolic risk on the gut microbiota.
    Balvers M; van den Born BH; Levin E; Nieuwdorp M
    Curr Opin Lipidol; 2021 Feb; 32(1):38-54. PubMed ID: 33332920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark.
    Pinna NK; Anjana RM; Saxena S; Dutta A; Gnanaprakash V; Rameshkumar G; Aswath S; Raghavan S; Rani CSS; Radha V; Balasubramanyam M; Pant A; Nielsen T; Jørgensen T; Færch K; Kashani A; Silva MCA; Vestergaard H; Hansen TH; Hansen T; Arumugam M; Nair GB; Das B; Pedersen O; Mohan V; Mande SS
    Genome Med; 2021 Mar; 13(1):36. PubMed ID: 33658065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Milk Replacer-Based
    Wang Y; An M; Zhang Z; Zhang W; Kulyar MF; Iqbal M; He Y; Li F; An T; Li H; Luo X; Yang S; Li J
    Microbiol Spectr; 2022 Aug; 10(4):e0115522. PubMed ID: 35771011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut Microbiome Modifies the Association Between a Mediterranean Diet and Diabetes in USA Hispanic/ Latino Population.
    Wang DD; Qi Q; Wang Z; Usyk M; Sotres-Alvarez D; Mattei J; Tamez M; Gellman MD; Daviglus M; Hu FB; Stampfer MJ; Huttenhower C; Knight R; Burk RD; Kaplan RC
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e924-e934. PubMed ID: 34747479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.
    Meyer KA; Bennett BJ
    Curr Diab Rep; 2016 Oct; 16(10):93. PubMed ID: 27541295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
    Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
    BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome Activity Contributes to Prediction of Individual Variation in Glycemic Response in Adults.
    Tily H; Patridge E; Cai Y; Gopu V; Gline S; Genkin M; Lindau H; Sjue A; Slavov I; Perlina A; Klitgord N; Messier H; Vuyisich M; Banavar G
    Diabetes Ther; 2022 Jan; 13(1):89-111. PubMed ID: 34799839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Nutrition and the Microbiome, Part I: Current State of the Science.
    Mills S; Stanton C; Lane JA; Smith GJ; Ross RP
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31022973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.
    Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK
    mBio; 2017 Oct; 8(5):. PubMed ID: 29042495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the Building Research in CRC prevention (BRIDGE-CRC) trial: a 6-month, parallel group Mediterranean diet and weight loss randomized controlled lifestyle intervention targeting the bile acid-gut microbiome axis to reduce colorectal cancer risk among African American/Black adults with obesity.
    McLeod A; Wolf P; Chapkin RS; Davidson LA; Ivanov I; Berbaum M; Williams LR; Gaskins HR; Ridlon J; Sanchez-Flack J; Blumstein L; Schiffer L; Hamm A; Cares K; Antonic M; Bernabe BP; Fitzgibbon M; Tussing-Humphreys L
    Trials; 2023 Feb; 24(1):113. PubMed ID: 36793105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.